Outcomes
diarrhoea, multiple failure, malnutrition
SECONDARY, MEASLES, MALNUTRITION
The primary outcomes of the trial were assessed at the midline and endline time points. For the CCT intervention, these were measles vaccination coverage, defined as the proportion of children aged 9 to 59 months who had received MCV1, and “EPI vaccination coverage,” defined as the proportion of children aged <60 months who had received all their vaccinations according to the EPI schedule and their age (see Following trial registration with ISRCTN, the name of the “EPI vaccination coverage” outcome was changed to “Timely Vaccination” to align better with terminology used in the literature, and “Pentavalent series completion,” defined as the proportion of children aged 12 to 23 months that had received all 3 does of Pentavalent vaccine, was added as an additional indicator of vaccination coverage.The secondary outcomes of the trial were as follows: acute malnutrition incidence, assessed as a single failure; mortality incidence; all-cause morbidity incidence, assessed as a single failure; exclusive breastfeeding in children, defined as the proportion of exclusively breastfed children aged <6 months; and the CSMF obtained from VA interviews. Other outcomes of the trial included the following: all-cause morbidity, assessed as multiple failure; diarrhoea incidence, assessed as a single and multiple failure; measles incidence, assessed as a single failure; total, food, and nonfood household expenditure; and the food security indicators household diet diversity (HDDS) and the rCSI.